Delivery Order SPE2DB25D3020-SPE2DB25FWKHX
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,830.88 contract is for the delivery of Oxymorphone HCl ER 20 mg tablets in 60-count packages. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.00 firm fixed-price delivery order is for the supply of 4566779797 - Oxymorphone HCL ER 20 MG Tablets in 60-count packages. The contract has a completion date of December 23, 2024. This award is associated with Amerisourcebergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxymorphone HCL ER Tablets 20mg, a prescription pain medication. The contract has a firm fixed price, a ceiling value of $8,605.76, and a period of performance through April 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.03 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER 10 mg tablets. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.95, is for the delivery of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,981.75 firm fixed price delivery order is for the supply of 4565505770 - Oxymorphone HCL ER 20 MG TAB 60S, a pharmaceutical product. The award has an ultimate completion date of August 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs)...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKHXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA and its Medical Supply Chain, delivering medications across multiple therapeutic domains including pain management, neurological treatments, diabetes medications, antibiotics, and specialty medical supplies. All reviewed contract awards demonstrate AmerisourceBergen's capability to meet federal procurement requirements through open competition, with delivery orders utilizing firm fixed pricing across varying transaction sizes. The company also serves additional federal customers including the Defense Health Agency and U.S. Coast Guard through its flexible contract vehicles supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/29/25 |